There were two objections to Innova's Antigen test in

New Post Public Reply Private Reply Replies (1) Message Board
Puravida19
383
There were two objections to Innova's Antigen test in England. The first had to do with how well the test worked and the second with the fact that some wanted British manufacturers to get contracts.

I'm anticipating the new British Innova factory will make product with quantum dots which will outperform Innova's current product, and everyone else's, many times over. There will be no question.

Manufacturing in England brings jobs and taxes there and takes away the foreign-made objection for Innova's products. Innova becomes more competitive by having more control over manufacturing and eliminates international shipping costs, which are huge and sometimes unpredictable in costs and reliability.

Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring the Surge of the Air Cargo Market to USD 217.74 Billion

Updated Category News Views 33

Growth of the Air Cargo Market The air cargo market is on an exhilarating growth trajectory, anticipated to reach a staggering USD 217.74 billion in revenue. This expansion is propelled by several factors, chiefly the rising popularity of e-commerce and a globalized economy. As consumers increasingly turn to online shopping, the demand for swift and reliable delivery...

Continue Reading
Swiss National Bank Board Member Confirms Inflation Stability

Updated Category News Views 93

Swiss National Bank Board Insights on Inflation Trends Inflation has been a topic of concern for central banks worldwide, but recently, a representative from the Swiss National Bank (SNB), Petra Tschudin, shared some encouraging news regarding the current inflation climate. Current Inflation Rates and Expectations In October, inflation rates in Switzerland dropped to a...

Continue Reading
MindMed Initiates Phase 3 Study for MM120 in Anxiety Treatment

Updated Category News Views 326

MindMed Begins Journey with Phase 3 Study of MM120 Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) has crossed a significant milestone in its mission to provide breakthrough treatments for brain health disorders. The clinical-stage biopharmaceutical company has announced that the first patient is now dosed in its pivotal Phase 3 Voyage study of MM120 Orally Disintegrating...

Continue Reading
William Silva Takes Charge of Mass Timber Initiatives at Swinerton

Updated Category News Views 177

William Silva Appointed as Director of National Mass Timber Swinerton Builders continues to enhance its mass timber capabilities with the recent appointment of William Silva as the Director of National Mass Timber. This decision emphasizes Swinerton's unwavering commitment to advancing mass timber construction, showcasing its leadership in the industry. Creating a Hub for...

Continue Reading
GlobalFoundries Teams Up with MIT for Semiconductor Breakthroughs

Updated Category News Views 95

GlobalFoundries and MIT's New Research Partnership In a significant development for the semiconductor industry, GlobalFoundries (NASDAQ: GFS) and the Massachusetts Institute of Technology (MIT) have embarked on an exciting collaboration aimed at enhancing the research and innovation surrounding essential chips for artificial intelligence (AI) and other critical...

Continue Reading